Celgene Corporation plans to present at four upcoming investor conferences and events where Celgene management will provide an overview of the Company.
The events will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.
Thursday, May 24, 2018, Celgene will host an R&D Deep Dive on Multiple Myeloma at 1:30pm ET
Wednesday, May 30, 2018, Celgene will present at the Sanford C. Bernstein Strategic Decisions Conference at 3:00 pm ET
Sunday, June 3, 2018, Celgene will host an Analyst & Investor Event at the American Society of Clinical Oncology (ASCO) Annual Meeting at 7:30 pm ET
Wednesday, June 6, 2018, Celgene will present at the Jefferies 2018 Global Healthcare Conference at 1:30 pm ET
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com
